Внедрение, проблемы ресурса и ревизия
8.1 Местное выполнение
Есть сообщения, что внедрение умеренной гипотермии после остановки сердца отстает в большей части развитого мира – несколько обзоров последних двух лет сообщают,
что только приблизительно 25% ОИТ когда-либо использовали эту терапию [3]. [215-218]
Однако, об успешном внедрение гипотермии сейчас сообщают много центров [2 +]. [15 38 39 59 114 219]
‘
Алгоритм помощи после остановки сердца включает [4]: [12]
1. Ранняя коронарная реперфузия и нормализация гемодинамики
2. Контроль вентиляции
3. Контроль за глюкозой крови
4. Температурный контроль
5. Лечение судорожных приступов.
Местное внедрение алгоритма лечения после остановки сердца требует сотрудничества
врачей и медсестер нескольких специальностей, в частности, специалистов, работающих в области интенсивной терапии и реанимации, экстренной медицинской помощи и кардиологии. Адаптация местных протоколов оказания помощи должна быть проведена совместно представителями всех этих дисциплин.
8.2 Привлечение ресурса
Многие из вмешательств, применяемых в постреанимационный период, не требуют
дорогого оборудования. У более дорогих систем охлаждения есть небольшие преимущества, но они, в любом случае, не являются существенными. Достижение адекватного среднего артериального давления и контроль глюкозы крови - также относительно недорогие вмешательства. В некоторые системах здравоохранения отсутствие интервенционных систем кардиологии мешает осуществлению своевременного ЧКВ в первые 24 часа, но в большинстве случаев возможно достигнуть ранней реперфузии посредством тромболитической терапии. Использование гипотермии не должно значительно увеличивать продолжительность пребывания в ОИТ. Данные, подтверждающие это, ожидаются.
8.3 Ключевые пункты для ревизии
Оказание помощи после остановки сердца должно быть предметом регулярной ревизии. Результат лечения пациентов, поступивших в ОИТ после остановки сердца, должен быть предметом регулярной и непрерывной ревизии.
8.4 Рекомендации для исследования
Следующие ключевые вопросы исследований, касающиеся послереанимационного периода, должны быть адаптированы из данных, собранных рабочими группами AHA/ILCOR [4]. [10 220].
8.4.1 Эпидемиология
Изучение и контроль тенденций прогноза после остановки сердца в Великобритании.
8.4.2 Патофизиология
1. Механизмы и время течения комы после остановки сердца
2. Механизмы и продолжительность нейродегенерации после остановки сердца
3. Механизмы и продолжительность миокардиальной дисфункции после остановки сердца
4. Механизмы и продолжительность доставки кислорода и его утилизации после остановки сердца
5. Роль внутрисосудистой коагуляции в дисфункции и недостаточности органов после остановки сердца
6. Механизм, продолжительность и значение надпочечниковой недостаточности после остановки сердца.
8.4.3 Терапия
1. Оптимальное применение терапевтической гипотермии у пациента после остановки сердца.
a. Какая польза для пациентов?
b. Оптимальная целевая температура, начало, продолжительность, и уровень нагревания
c. Самая эффективная техника охлаждения – внешняя или внутренняя
d. Показания для использования миорелаксантов
2. Показания для раннего чрезкожного коронарного вмешательства
3. Оптимальная терапия миокардиальной дисфункции после остановки сердца:
a. медикаментозная
b. механическая
4. Клиническая польза контролируемой реоксигенации
5. Клиническая польза достижения ранней оптимизации гемодинамики
6. Оптимальные цели (параметры и целевые диапазоны) для ранней оптимизации гемодинамики:
a. Среднее артериальное давление
b. Центральное венозное давление
c. Насыщение кислородом центральной венозной крови и смешанной венозной крови
d. Концентрация гемоглобина и переливание крови
e. Концентрация лактата
f. Диурез
g. Доставка кислорода
h. Другое.
7. Клиническая польза контроля за глюкозой и оптимального целевого диапазона глюкозы.
8. Роль высоко-объемного гемодиализа
9. Роль ранней глюкокортикоидной терапии
10. Роль профилактического назначения антиконвульсантов
11. Роль определенного периода седации и вентиляции
12. Роль нейропротективных препаратов.
8.4.4 Прогноз
1. Оптимальная схема принятия решения для определения нецелесообразности дальнейшего продолжения лечения
2. Воздействие терапевтической гипотермии на достоверность предсказания
нецелесообразности.
8.4.5 Педиатрия
1. Доказательства возможности применения для детей знаний, упомянутых выше
2. Роль экстракорпоральной мембранной оксигенации в терапии остановки сердца у детей и в ведении детей после остановки.
8.4.5 Барьеры
1. Наиболее эффективный подход для осуществления терапевтической гипотермии и
оптимизация помощи пациентам после остановки сердца
2. Ценность региональной помощи после остановки сердца специализированными центрами.
Ссылки
1. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world:
Global Burden of Disease Study. Lancet 1997; 349: 1269-76.
2. Zheng ZJ, Croft JB, Giles WH, Mensah GA. Sudden cardiac death in the
United States, 1989 to 1998. Circulation 2001; 104: 2158-63.
3. Pell JP, Sirel JM, Marsden AK, et al. Presentation, management, and
outcome of out of hospital cardiopulmonary arrest: comparison by underlying
aetiology. Heart 2003; 89: 839-42.
4. Cobb LA, Fahrenbruch CE, Olsufka M, Copass MK. Changing incidence of
out-of-hospital ventricular fibrillation, 1980-2000. JAMA 2002; 288: 3008-13.
5. Atwood C, Eisenberg MS, Herlitz J, Rea TD. Incidence of EMS-treated out-ofhospital
cardiac arrest in Europe. Resuscitation 2005; 67: 75-80.
6. Hodgetts TJ, Kenward G, Vlackonikolis I, et al. Incidence, location and
reasons for avoidable in-hospital cardiac arrest in a district general hospital.
Resuscitation 2002; 54: 115-23.
7. Gwinnutt CL, Columb M, Harris R. Outcome after cardiac arrest in adults in
UK hospitals: effect of the 1997 guidelines. Resuscitation 2000; 47: 125-35.
8. Peberdy MA, Kaye W, Ornato JP, et al. Cardiopulmonary resuscitation of
adults in the hospital: a report of 14720 cardiac arrests from the National
Registry of Cardiopulmonary Resuscitation. Resuscitation 2003; 58: 297-308.
9. Adrie C, Adib-Conquy M, Laurent I, et al. Successful cardiopulmonary
resuscitation after cardiac arrest as a "sepsis-like" syndrome. Circulation
2002; 106: 562-8.
10. Neumar R, Nolan JP. AHA/ILCOR Post-Cardiac Arrest Statement of Science.
Circulation 2008; In Press.
11. Soar J, Nolan JP. Mild hypothermia for post cardiac arrest syndrome. BMJ
2007; 335: 459-60.
12. Nolan JP, Soar J. Post resuscitation care – time for a care bundle?
Resuscitation 2008; 76.
13. Nolan JP, Laver SR, Welch CA, et al. Outcome following admission to UK
intensive care units after cardiac arrest: a secondary analysis of the ICNARC
Case Mix Programme Database. Anaesthesia 2007; 62: 1207-16.
14. Laver S, Farrow C, Turner D, Nolan J. Mode of death after admission to an
intensive care unit following cardiac arrest. Intensive Care Med 2004; 30:
2126-8.
15. Sunde K, Pytte M, Jacobsen D, et al. Implementation of a standardised
treatment protocol for post resuscitation care after out-of-hospital cardiac
arrest. Resuscitation 2007.
16. Langhelle A, Tyvold SS, Lexow K, et al. In-hospital factors associated with
improved outcome after out-of-hospital cardiac arrest. A comparison between
four regions in Norway. Resuscitation 2003; 56: 247-63.
17. Langhelle A, Nolan J, Herlitz J, et al. Recommended guidelines for reviewing,
reporting, and conducting research on post-resuscitation care: the Utstein
style. Resuscitation 2005; 66: 271-83.
18. Herlitz J, Engdahl J, Svensson L, et al. Major differences in 1-month survival
between hospitals in Sweden among initial survivors of out-of-hospital cardiac
arrest. Resuscitation 2006; 70: 404-9.
19. International Liaison Committee on Resuscitation. 2005 International
Consensus on Cardiopulmonary Resuscitation and Emergency
Cardiovascular Care Science with Treatment Recommendations.
Resuscitation 2005; 67: 157-341.
20. Sundgreen C, Larsen FS, Herzog TM, et al. Autoregulation of cerebral blood
flow in patients resuscitated from cardiac arrest. Stroke 2001; 32: 128-32.
21. Buunk G, van der Hoeven JG, Meinders AE. Cerebrovascular reactivity in
comatose patients resuscitated from a cardiac arrest. Stroke 1997; 28: 1569-
73.
22. Buunk G, van der Hoeven JG, Meinders AE. A comparison of near-infrared
spectroscopy and jugular bulb oximetry in comatose patients resuscitated
from a cardiac arrest. Anaesthesia 1998; 53: 13-9.
23. Roine RO, Launes J, Nikkinen P, Lindroth L, Kaste M. Regional cerebral
blood flow after human cardiac arrest. A hexamethylpropyleneamine oxime
single photon emission computed tomographic study. Arch Neurol 1991; 48:
625-9.
24. Beckstead JE, Tweed WA, Lee J, MacKeen WL. Cerebral blood flow and
metabolism in man following cardiac arrest. Stroke 1978; 9: 569-73.
25. Buunk G, van der Hoeven JG, Frolich M, Meinders AE. Cerebral
vasoconstriction in comatose patients resuscitated from a cardiac arrest?
Intensive Care Med 1996; 22: 1191-6.
26. Muizelaar JP, Marmarou A, Ward JD, et al. Adverse effects of prolonged
hyperventilation in patients with severe head injury: a randomized clinical trial.
J Neurosurg 1991; 75: 731-9.
27. Vereczki V, Martin E, Rosenthal RE, et al. Normoxic resuscitation after
cardiac arrest protects against hippocampal oxidative stress, metabolic
dysfunction, and neuronal death. J Cereb Blood Flow Metab 2006; 26: 821-
35.
28. Richards EM, Fiskum G, Rosenthal RE, Hopkins I, McKenna MC. Hyperoxic
reperfusion after global ischemia decreases hippocampal energy metabolism.
Stroke 2007; 38: 1578-84.
29. Balan IS, Fiskum G, Hazelton J, Cotto-Cumba C, Rosenthal RE. Oximetryguided
reoxygenation improves neurological outcome after experimental
cardiac arrest. Stroke 2006; 37: 3008-13.
30. Huikuri HV, Castellanos A, Myerburg RJ. Sudden death due to cardiac
arrhythmias. N Engl J Med 2001; 345: 1473-82.
31. Zipes DP, Wellens HJ. Sudden cardiac death. Circulation 1998; 98: 2334-51.
32. Spaulding CM, Joly LM, Rosenberg A, et al. Immediate coronary angiography
in survivors of out-of-hospital cardiac arrest. N Engl J Med 1997; 336: 1629-
33.
33. Bendz B, Eritsland J, Nakstad AR, et al. Long-term prognosis after out-ofhospital
cardiac arrest and primary percutaneous coronary intervention.
Resuscitation 2004; 63: 49-53.
34. Keelan PC, Bunch TJ, White RD, Packer DL, Holmes DR, Jr. Early direct
coronary angioplasty in survivors of out-of-hospital cardiac arrest. Am J
Cardiol 2003; 91: 1461-3, A6.
35. Quintero-Moran B, Moreno R, Villarreal S, et al. Percutaneous coronary
intervention for cardiac arrest secondary to ST-elevation acute myocardial
infarction. Influence of immediate paramedical/medical assistance on clinical
outcome. J Invasive Cardiol 2006; 18: 269-72.
36. Garot P, Lefevre T, Eltchaninoff H, et al. Six-month outcome of emergency
percutaneous coronary intervention in resuscitated patients after cardiac
arrest complicating ST-elevation myocardial infarction. Circulation 2007; 115:
1354-62.
37. Gorjup V, Radsel P, Kocjancic ST, Erzen D, Noc M. Acute ST-elevation
myocardial infarction after successful cardiopulmonary resuscitation.
Resuscitation 2007; 72: 379-85.
38. Hovdenes J, Laake JH, Aaberge L, Haugaa H, Bugge JF. Therapeutic
hypothermia after out-of-hospital cardiac arrest: experiences with patients
treated with percutaneous coronary intervention and cardiogenic shock. Acta
Anaesthesiol Scand 2007; 51: 137-42.
39. Knafelj R, Radsel P, Ploj T, Noc M. Primary percutaneous coronary
intervention and mild induced hypothermia in comatose survivors of
ventricular fibrillation with ST-elevation acute myocardial infarction.
Resuscitation 2007; 74: 227-34.
40. Bottiger BW, Bode C, Kern S, et al. Efficacy and safety of thrombolytic
therapy after initially unsuccessful cardiopulmonary resuscitation: a
prospective clinical trial. Lancet 2001; 357: 1583-5.
41. van Campen LC, van Leeuwen GR, Verheugt FW. Safety and efficacy of
thrombolysis for acute myocardial infarction in patients with prolonged out-ofhospital
cardiopulmonary resuscitation. Am J Cardiol 1994; 73: 953-5.
42. Abu-Laban RB, Christenson JM, Innes GD, et al. Tissue plasminogen
activator in cardiac arrest with pulseless electrical activity. N Engl J Med
2002; 346: 1522-8.
43. 2005 International Consensus on Cardiopulmonary Resuscitation and
Emergency Cardiovascular Care Science with Treatment Recommendations.
Part 5: Acute coronary syndromes. Resuscitation 2005; 67: 249-69.
44. Andersen HR, Nielsen TT, Rasmussen K, et al. A comparison of coronary
angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J
Med 2003; 349: 733-42.
45. Berger PB, Ellis SG, Holmes DR, Jr., et al. Relationship between delay in
performing direct coronary angioplasty and early clinical outcome in patients
with acute myocardial infarction: results from the global use of strategies to
open occluded arteries in Acute Coronary Syndromes (GUSTO-IIb) trial.
Circulation 1999; 100: 14-20.
46. A clinical trial comparing primary coronary angioplasty with tissue
plasminogen activator for acute myocardial infarction. The Global Use of
Strategies to Open Occluded Coronary Arteries in Acute Coronary
Syndromes (GUSTO IIb) Angioplasty Substudy Investigators. N Engl J Med
1997; 336: 1621-8.
47. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute
myocardial infarction complicated by cardiogenic shock. SHOCK
Investigators. Should We Emergently Revascularize Occluded Coronaries for
Cardiogenic Shock. N Engl J Med 1999; 341: 625-34.
48. Widimsky P, Budesinsky T, Vorac D, et al. Long distance transport for primary
angioplasty vs immediate thrombolysis in acute myocardial infarction. Final
results of the randomized national multicentre trial--PRAGUE-2. Eur Heart J
2003; 24: 94-104.
49. Zijlstra F, Patel A, Jones M, et al. Clinical characteristics and outcome of
patients with early (<2 h), intermediate (2-4 h) and late (>4 h) presentation
treated by primary coronary angioplasty or thrombolytic therapy for acute
myocardial infarction. Eur Heart J 2002; 23: 550-7.
50. Dalby M, Bouzamondo A, Lechat P, Montalescot G. Transfer for primary
angioplasty versus immediate thrombolysis in acute myocardial infarction: a
meta-analysis. Circulation 2003; 108: 1809-14.
51. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous
thrombolytic therapy for acute myocardial infarction: a quantitative review of
23 randomised trials. Lancet 2003; 361: 13-20.
52. Weaver WD, Simes RJ, Betriu A, et al. Comparison of primary coronary
angioplasty and intravenous thrombolytic therapy for acute myocardial
infarction: a quantitative review [published correction appears in JAMA.
1998;279:1876]. JAMA 1997; 278: 2093-8.
53. Keeley EC, Boura JA, Grines CL. Comparison of primary and facilitated
percutaneous coronary interventions for ST-elevation myocardial infarction:
quantitative review of randomised trials. Lancet 2006; 367: 579-88.
54. Laurent I, Monchi M, Chiche JD, et al. Reversible myocardial dysfunction in
survivors of out-of-hospital cardiac arrest. J Am Coll Cardiol 2002; 40: 2110-6.
55. Ruiz-Bailen M, Aguayo de Hoyos E, Ruiz-Navarro S, et al. Reversible
myocardial dysfunction after cardiopulmonary resuscitation. Resuscitation
2005; 66: 175-81.
56. Kern KB, Hilwig RW, Rhee KH, Berg RA. Myocardial dysfunction after
resuscitation from cardiac arrest: an example of global myocardial stunning. J
Am Coll Cardiol 1996; 28: 232-40.
57. Adrie C, Adib-Conquy M, Laurent I, et al. Successful cardiopulmonary
resuscitation after cardiac arrest as a "sepsis-like" syndrome. Circulation
2002; 106: 562-8.
58. Mullner M, Sterz F, Binder M, et al. Arterial blood pressure after human
cardiac arrest and neurological recovery. Stroke 1996; 27: 59-62.
59. Oddo M, Schaller MD, Feihl F, Ribordy V, Liaudet L. From evidence to clinical
practice: effective implementation of therapeutic hypothermia to improve
patient outcome after cardiac arrest. Crit Care Med 2006; 34: 1865-73.
60. Myerburg RJ, Briese FW, Conde C, et al. Long-term antiarrhythmic therapy in
survivors of prehospital cardiac arrest. Initial 18 months' experience. JAMA
1977; 238: 2621-4.
61. Somberg JC, Laux B, Wynn J, Keefe D, Miura DS. Lorcainide therapy in a
cardiac arrest population. Am Heart J 1986; 111: 648-53.
62. Moosvi AR, Goldstein S, VanderBrug Medendorp S, et al. Effect of empiric
antiarrhythmic therapy in resuscitated out-of-hospital cardiac arrest victims
with coronary artery disease. Am J Cardiol 1990; 65: 1192-7.
63. Haverkamp W, Martinez-Rubio A, Hief C, et al. Efficacy and safety of d,lsotalol
in patients with ventricular tachycardia and in survivors of cardiac
arrest. J Am Coll Cardiol 1997; 30: 487-95.
64. Hallstrom AP, Cobb LA, Yu BH, Weaver WD, Fahrenbruch CE. An
antiarrhythmic drug experience in 941 patients resuscitated from an initial
cardiac arrest between 1970 and 1985. Am J Cardiol 1991; 68: 1025-31.
65. Peter T, Hamer A, Weiss D, Mandel WJ. Prognosis after sudden cardiac
death without associated myocardial infarction: one year follow-up of empiric
therapy with amiodarone. Am Heart J 1984; 107: 209-13.
66. Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the
CASCADE Study). The CASCADE Investigators. Am J Cardiol 1993; 72: 280-
7.
67. Wever EFD, Hauer RNW, Van Capelle FJL, et al. Randomized study of
implantable defibrillator as first-choice therapy versus conventional strategy in
postinfarct sudden death survivors. Circulation 1995; 91: 2195-203.
68. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in
patients resuscitated from near-fatal ventricular arrhythmias. The
Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl
J Med 1997; 337: 1576-83.
69. Connolly SJ, Gent M, Roberts RS, et al. Canadian implantable defibrillator
study (CIDS): A randomized trial of the implantable cardioverter defibrillator
against amiodarone. Circulation 2000; 101: 1297-302.
70. Connolly SJ, Hallstrom AP, Cappato R, et al. Metal-analysis of the
implantable cardioverter defibrillator secondary prevention trials. Eur Heart J
2000; 21: 2071-8.
71. Hennersdorf MG, Niebch V, Vester EG, et al. Long-term follow-up of sudden
cardiac arrest survivors and electrophysiologically guided antiarrhythmic
therapy. Cardiology 2003; 99: 190-7.
72. Connolly SJ, Dorian P, Roberts RS, et al. Comparison of beta-blockers,
amiodarone plus beta-blockers, or sotalol for prevention of shocks from
implantable cardioverter defibrillators: the OPTIC Study: a randomized trial.
Jama 2006; 295: 165-71.
73. Martin GB, Nowak RM, Cisek JE, Carden DL, Tomlanovich MC.
Hyperkalemia during human cardiopulmonary resuscitation: incidence and
ramifications. J Emerg Med 1989; 7: 109-13.
74. Hekimian G, Baugnon T, Thuong M, et al. Cortisol levels and adrenal reserve
after successful cardiac arrest resuscitation. Shock 2004; 22: 116-9.
75. Schultz CH, Rivers EP, Feldkamp CS, et al. A characterization of
hypothalamic-pituitary-adrenal axis function during and after human cardiac
arrest. Crit Care Med 1993; 21: 1339-47.
76. Pene F, Hyvernat H, Mallet V, et al. Prognostic value of relative adrenal
insufficiency after out-of-hospital cardiac arrest. Intensive Care Med 2005; 31:
627-33.
77. Kim JJ, Lim YS, Shin JH, et al. Relative adrenal insufficiency after cardiac
arrest: impact on postresuscitation disease outcome. Am J Emerg Med 2006;
24: 684-8.
78. Miller JB, Donnino MW, Rogan M, Goyal N. Relative adrenal insufficiency in
post-cardiac arrest shock is under-recognized. Resuscitation 2007.
79. Tsai MS, Huang CH, Chang WT, et al. The effect of hydrocortisone on the
outcome of out-of-hospital cardiac arrest patients: a pilot study. Am J Emerg
Med 2007; 25: 318-25.
80. Adrie C, Monchi M, Laurent I, et al. Coagulopathy after successful
cardiopulmonary resuscitation following cardiac arrest: implication of the
protein C anticoagulant pathway. J Am Coll Cardiol 2005; 46: 21-8.
81. Laurent I, Adrie C, Vinsonneau C, et al. High-volume hemofiltration after outof-
hospital cardiac arrest: a randomized study. J Am Coll Cardiol 2005; 46:
432-7.
82. Neumar RW. Molecular mechanisms of ischemic neuronal injury. Ann Emerg
Med 2000; 36: 483-506.
83. Lipton P. Ischemic cell death in brain neurons. Physiol Rev 1999; 79: 1431-
568.
84. Bano D, Nicotera P. Ca2+ signals and neuronal death in brain ischemia.
Stroke 2007; 38: 674-6.
85. Ames A, 3rd, Wright RL, Kowada M, Thurston JM, Majno G. Cerebral
ischemia. II. The no-reflow phenomenon. Am J Pathol 1968; 52: 437-53.
86. Wolfson SK, Jr., Safar P, Reich H, et al. Dynamic heterogeneity of cerebral
hypoperfusion after prolonged cardiac arrest in dogs measured by the stable
xenon/CT technique: a preliminary study. Resuscitation 1992; 23: 1-20.
87. Nishizawa H, Kudoh I. Cerebral autoregulation is impaired in patients
resuscitated after cardiac arrest. Acta Anaesthesiol Scand 1996; 40: 1149-53.
88. Angelos MG, Ward KR, Hobson J, Beckley PD. Organ blood flow following
cardiac arrest in a swine low-flow cardiopulmonary bypass model.
Resuscitation 1994; 27: 245-54.
89. Buunk G, van der Hoeven JG, Meinders AE. Cerebral blood flow after cardiac
arrest. Neth J Med 2000; 57: 106-12.
90. Sakabe T, Tateishi A, Miyauchi Y, et al. Intracranial pressure following
cardiopulmonary resuscitation. Intensive Care Med 1987; 13: 256-9.
91. Morimoto Y, Kemmotsu O, Kitami K, Matsubara I, Tedo I. Acute brain swelling
after out-of-hospital cardiac arrest: pathogenesis and outcome. Crit Care Med
1993; 21: 104-10.
92. Torbey MT, Selim M, Knorr J, Bigelow C, Recht L. Quantitative analysis of the
loss of distinction between gray and white matter in comatose patients after
cardiac arrest. Stroke 2000; 31: 2163-7.
93. Iida K, Satoh H, Arita K, et al. Delayed hyperemia causing intracranial
hypertension after cardiopulmonary resuscitation. Crit Care Med 1997; 25:
971-6.
94. Rello J, Diaz E, Roque M, Valles J. Risk factors for developing pneumonia
within 48 hours of intubation. Am J Respir Crit Care Med 1999; 159: 1742-6.
95. Tortorici MA, Kochanek PM, Poloyac SM. Effects of hypothermia on drug
disposition, metabolism, and response: A focus of hypothermia-mediated
alterations on the cytochrome P450 enzyme system. Crit Care Med 2007; 35:
2196-204.
96. Zandbergen EG, Hijdra A, Koelman JH, et al. Prediction of poor outcome
within the first 3 days of postanoxic coma. Neurology 2006; 66: 62-8.
97. Krumholz A, Stern BJ, Weiss HD. Outcome from coma after cardiopulmonary
resuscitation: relation to seizures and myoclonus. Neurology 1988; 38: 401-5.
98. Levy DE, Caronna JJ, Singer BH, et al. Predicting outcome from hypoxicischemic
coma. JAMA 1985; 253: 1420-6.
99. Snyder BD, Hauser WA, Loewenson RB, et al. Neurologic prognosis after
cardiopulmonary arrest, III: seizure activity. Neurology 1980; 30: 1292-7.
100. Ingvar M. Cerebral blood flow and metabolic rate during seizures.
Relationship to epileptic brain damage. Ann N Y Acad Sci 1986; 462: 194-
206.
101. Caviness JN, Brown P. Myoclonus: current concepts and recent advances.
Lancet Neurol 2004; 3: 598-607.
102. Wijdicks EF. Propofol in myoclonus status epilepticus in comatose patients
following cardiac resuscitation. J Neurol Neurosurg Psychiatry 2002; 73: 94-5.
103. Rundgren M, Rosen I, Friberg H. Amplitude-integrated EEG (aEEG) predicts
outcome after cardiac arrest and induced hypothermia. Intensive Care Med
2006; 32: 836-42.
104. Takino M, Okada Y. Hyperthermia following cardiopulmonary resuscitation.
Intensive Care Med 1991; 17: 419-20.
105. Takasu A, Saitoh D, Kaneko N, Sakamoto T, Okada Y. Hyperthermia: is it an
ominous sign after cardiac arrest? Resuscitation 2001; 49: 273-7.
106. Hickey RW, Kochanek PM, Ferimer H, et al. Induced hyperthermia
exacerbates neurologic neuronal histologic damage after asphyxial cardiac
arrest in rats. Crit Care Med 2003; 31: 531-5.
107. Zeiner A, Holzer M, Sterz F, et al. Hyperthermia after cardiac arrest is
associated with an unfavorable neurologic outcome. Arch Intern Med 2001;
161: 2007-12.
108. Coimbra C, Boris-Moller F, Drake M, Wieloch T. Diminished neuronal damage
in the rat brain by late treatment with the antipyretic drug dipyrone or cooling
following cerebral ischemia. Acta Neuropathol (Berl) 1996; 92: 447-53.
109. Coimbra C, Drake M, Boris-Moller F, Wieloch T. Long-lasting neuroprotective
effect of postischemic hypothermia and treatment with an antiinflammatory/
antipyretic drug: evidence for chronic encephalopathic
processes following ischemia. Stroke 1996; 27: 1578-85.
110. Hypothermia After Cardiac Arrest Study Group. Mild therapeutic hypothermia
to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002;
346: 549-56.
111. Bernard SA, Gray TW, Buist MD, et al. Treatment of comatose survivors of
out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 2002;
346: 557-63.
112. Holzer M, Bernard SA, Hachimi-Idrissi S, et al. Hypothermia for
neuroprotection after cardiac arrest: systematic review and individual patient
data meta-analysis. Crit Care Med 2005; 33: 414-8.
113. Bernard SA, Jones BM, Horne MK. Clinical trial of induced hypothermia in
comatose survivors of out-of-hospital cardiac arrest. Ann Emerg Med 1997;
30: 146-53.
114. Busch M, Soreide E, Lossius HM, Lexow K, Dickstein K. Rapid
implementation of therapeutic hypothermia in comatose out-of-hospital
cardiac arrest survivors. Acta Anaesthesiol Scand 2006; 50: 1277-83.
115. Arrich J. Clinical application of mild therapeutic hypothermia after cardiac
arrest. Crit Care Med 2007; 35: 1041-7.
116. Holzer M, Mullner M, Sterz F, et al. Efficacy and safety of endovascular
cooling after cardiac arrest: cohort study and Bayesian approach. Stroke
2006; 37: 1792-7.
117. Hachimi-Idrissi S, Corne L, Ebinger G, Michotte Y, Huyghens L. Mild
hypothermia induced by a helmet device: a clinical feasibility study.
Resuscitation 2001; 51: 275-81.
118. Kim F, Olsufka M, Longstreth WT, Jr., et al. Pilot randomized clinical trial of
prehospital induction of mild hypothermia in out-of-hospital cardiac arrest
patients with a rapid infusion of 4 degrees C normal saline. Circulation 2007;
115: 3064-70.
119. Bernard S, Buist M, Monteiro O, Smith K. Induced hypothermia using large
volume, ice-cold intravenous fluid in comatose survivors of out-of-hospital
cardiac arrest: a preliminary report. Resuscitation 2003; 56: 9-13.
120. Virkkunen I, Yli-Hankala A, Silfvast T. Induction of therapeutic hypothermia
after cardiac arrest in prehospital patients using ice-cold Ringer's solution: a
pilot study. Resuscitation 2004; 62: 299-302.
121. Al-Senani FM, Graffagnino C, Grotta JC, et al. A prospective, multicenter pilot
study to evaluate the feasibility and safety of using the CoolGard System and
Icy catheter following cardiac arrest. Resuscitation 2004; 62: 143-50.
122. Kliegel A, Losert H, Sterz F, et al. Cold simple intravenous infusions
preceding special endovascular cooling for faster induction of mild
hypothermia after cardiac arrest--a feasibility study. Resuscitation 2005; 64:
347-51.
123. Haugk M, Sterz F, Grassberger M, et al. Feasibility and efficacy of a new noninvasive
surface cooling device in post-resuscitation intensive care medicine.
Resuscitation 2007.
124. Kim F, Olsufka M, Carlbom D, et al. Pilot study of rapid infusion of 2 L of 4
degrees C normal saline for induction of mild hypothermia in hospitalized,
comatose survivors of out-of-hospital cardiac arrest. Circulation 2005; 112:
715-9.
125. Polderman KH, Rijnsburger ER, Peerdeman SM, Girbes AR. Induction of
hypothermia in patients with various types of neurologic injury with use of
large volumes of ice-cold intravenous fluid. Crit Care Med 2005; 33: 2744-51.
126. Kliegel A, Janata A, Wandaller C, et al. Cold infusions alone are effective for
induction of therapeutic hypothermia but do not keep patients cool after
cardiac arrest. Resuscitation 2007; 73: 46-53.
127. Diringer MN, Reaven NL, Funk SE, Uman GC. Elevated body temperature
independently contributes to increased length of stay in neurologic intensive
care unit patients. Crit Care Med 2004; 32: 1489-95.
128. Keller E, Imhof HG, Gasser S, Terzic A, Yonekawa Y. Endovascular cooling
with heat exchange catheters: a new method to induce and maintain
hypothermia. Intensive Care Med 2003; 29: 939-43.
129. Schmutzhard E, Engelhardt K, Beer R, et al. Safety and efficacy of a novel
intravascular cooling device to control body temperature in neurologic
intensive care patients: a prospective pilot study. Crit Care Med 2002; 30:
2481-8.
130. Guluma KZ, Hemmen TM, Olsen SE, Rapp KS, Lyden PD. A trial of
therapeutic hypothermia via endovascular approach in awake patients with
acute ischemic stroke: methodology. Acad Emerg Med 2006; 13: 820-7.
131. Agnew DM, Koehler RC, Guerguerian AM, et al. Hypothermia for 24 hours
after asphyxic cardiac arrest in piglets provides striatal neuroprotection that is
sustained 10 days after rewarming. Pediatr Res 2003; 54: 253-62.
132. Hicks SD, DeFranco DB, Callaway CW. Hypothermia during reperfusion after
asphyxial cardiac arrest improves functional recovery and selectively alters
stress-induced protein expression. J Cereb Blood Flow Metab 2000; 20: 520-
30.
133. Sterz F, Safar P, Tisherman S, et al. Mild hypothermic cardiopulmonary
resuscitation improves outcome after prolonged cardiac arrest in dogs. Crit
Care Med 1991; 19: 379-89.
134. Xiao F, Safar P, Radovsky A. Mild protective and resuscitative hypothermia
for asphyxial cardiac arrest in rats. Am J Emerg Med 1998; 16: 17-25.
135. Katz LM, Young AS, Frank JE, Wang Y, Park K. Regulated hypothermia
reduces brain oxidative stress after hypoxic-ischemia. Brain Res 2004; 1017:
85-91.
136. Abella BS, Zhao D, Alvarado J, et al. Intra-arrest cooling improves outcomes
in a murine cardiac arrest model. Circulation 2004; 109: 2786-91.
137. Lawrence EJ, Dentcheva E, Curtis KM, et al. Neuroprotection with delayed
initiation of prolonged hypothermia after in vitro transient global brain
ischemia. Resuscitation 2005; 64: 383-8.
138. Kuboyama K, Safar P, Radovsky A, et al. Delay in cooling negates the
beneficial effect of mild resuscitative cerebral hypothermia after cardiac arrest
in dogs: a prospective, randomized study. Crit Care Med 1993; 21: 1348-58.
139. Wolff B, Machill K, Schumacher D, Schulzki I, Werner D. Early achievement
of mild therapeutic hypothermia and the neurologic outcome after cardiac
arrest. Int J Cardiol 2008.
140. Hovland A, Nielsen EW, Kluver J, Salvesen R. EEG should be performed
during induced hypothermia. Resuscitation 2006; 68: 143-6.
141. Polderman KH, Peerdeman SM, Girbes AR. Hypophosphatemia and
hypomagnesemia induced by cooling in patients with severe head injury. J
Neurosurg 2001; 94: 697-705.
142. Polderman KH. Application of therapeutic hypothermia in the intensive care
unit. Opportunities and pitfalls of a promising treatment modality--Part 2:
Practical aspects and side effects. Intensive Care Med 2004; 30: 757-69.
143. Calle PA, Buylaert WA, Vanhaute OA. Glycemia in the post-resuscitation
period. The Cerebral Resuscitation Study Group. Resuscitation 1989; 17
Suppl: S181-8; discussion S99-206.
144. Longstreth WT, Jr., Diehr P, Inui TS. Prediction of awakening after out-ofhospital
cardiac arrest. N Engl J Med 1983; 308: 1378-82.
145. Longstreth WT, Jr., Inui TS. High blood glucose level on hospital admission
and poor neurological recovery after cardiac arrest. Ann Neurol 1984; 15: 59-
63.
146. Longstreth WT, Jr., Copass MK, Dennis LK, et al. Intravenous glucose after
out-of-hospital cardiopulmonary arrest: a community-based randomized trial.
Neurology 1993; 43: 2534-41.
147. Mackenzie CF. A review of 100 cases of cardiac arrest and the relation of
potassium, glucose, and haemoglobin levels to survival. West Indian Med J
1975; 24: 39-45.
148. Mullner M, Sterz F, Binder M, et al. Blood glucose concentration after
cardiopulmonary resuscitation influences functional neurological recovery in
human cardiac arrest survivors. J Cereb Blood Flow Metab 1997; 17: 430-6.
149. Skrifvars MB, Pettila V, Rosenberg PH, Castren M. A multiple logistic
regression analysis of in-hospital factors related to survival at six months in
patients resuscitated from out-of-hospital ventricular fibrillation. Resuscitation
2003; 59: 319-28.
150. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress
hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a
systematic overview. Stroke 2001; 32: 2426-32.
151. Baird TA, Parsons MW, Phanh T, et al. Persistent poststroke hyperglycemia
is independently associated with infarct expansion and worse clinical
outcome. Stroke 2003; 34: 2208-14.
152. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in
the critically ill patients. N Engl J Med 2001; 345: 1359-67.
153. Van den Berghe G, Schoonheydt K, Becx P, Bruyninckx F, Wouters PJ.
Insulin therapy protects the central and peripheral nervous system of
intensive care patients. Neurology 2005; 64: 1348-53.
154. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in
the medical ICU. N Engl J Med 2006; 354: 449-61.
155. Katz LM, Wang Y, Ebmeyer U, Radovsky A, Safar P. Glucose plus insulin
infusion improves cerebral outcome after asphyxial cardiac arrest.
Neuroreport 1998; 9: 3363-7.
156. Oksanen T, Skrifvars MB, Varpula T, et al. Strict versus moderate glucose
control after resuscitation from ventricular fibrillation. Intensive Care Med
2007.
157. Finney SJ, Zekveld C, Elia A, Evans TW. Glucose control and mortality in
critically ill patients. JAMA 2003; 290: 2041-7.
158. Losert H, Sterz F, Roine RO, et al. Strict normoglycaemic blood glucose
levels in the therapeutic management of patients within 12h after cardiac
arrest might not be necessary. Resuscitation 2007.
159. Marik PE, Varon J. Intensive insulin therapy in the ICU: is it now time to jump
off the bandwagon? Resuscitation 2007; 74: 191-3.
160. Watkinson P, Barber VS, Young JD. Strict glucose control in the critically ill.
BMJ 2006; 332: 865-6.
161. Wijdicks EF, Hijdra A, Young GB, Bassetti CL, Wiebe S. Practice parameter:
prediction of outcome in comatose survivors after cardiopulmonary
resuscitation (an evidence-based review): report of the Quality Standards
Subcommittee of the American Academy of Neurology. Neurology 2006; 67:
203-10.
162. Skogvoll E, Isern E, Sangolt GK, Gisvold SE. In-hospital cardiopulmonary
resuscitation. 5 years' incidence and survival according to the Utstein
template. Acta Anaesthesiol Scand 1999; 43: 177-84.
163. Di Bari M, Chiarlone M, Fumagalli S, et al. Cardiopulmonary resuscitation of
older, inhospital patients: immediate efficacy and long-term outcome. Crit
Care Med 2000; 28: 2320-5.
164. Schwenzer KJ, Smith WT, Durbin CG, Jr. Selective application of
cardiopulmonary resuscitation improves survival rates. Anesth Analg 1993;
76: 478-84.
165. Ballew KA, Philbrick JT, Caven DE, Schorling JB. Predictors of survival
following in-hospital cardiopulmonary resuscitation. A moving target. Arch
Intern Med 1994; 154: 2426-32.
166. Tunstall-Pedoe H, Bailey L, Chamberlain DA, et al. Survey of 3765
cardiopulmonary resuscitations in British hospitals (the BRESUS Study):
methods and overall results. BMJ 1992; 304: 1347-51.
167. Cooper S, Janghorbani M, Cooper G. A decade of in-hospital resuscitation:
outcomes and prediction of survival? Resuscitation 2006; 68: 231-7.
168. de Vos R, Koster RW, De Haan RJ, et al. In-hospital cardiopulmonary
resuscitation: prearrest morbidity and outcome. Arch Intern Med 1999; 159:
845-50.
169. Cooper S, Cade J. Predicting survival, in-hospital cardiac arrests:
resuscitation survival variables and training effectiveness. Resuscitation
1997; 35: 17-22.
170. Rogove HJ, Safar P, Sutton-Tyrrell K, Abramson NS. Old age does not
negate good cerebral outcome after cardiopulmonary resuscitation: analyses
from the brain resuscitation clinical trials. The Brain Resuscitation Clinical
Trial I and II Study Groups. Crit Care Med 1995; 23: 18-25.
171. Adrie C, Cariou A, Mourvillier B, et al. Predicting survival with good
neurological recovery at hospital admission after successful resuscitation of
out-of-hospital cardiac arrest: the OHCA score. Eur Heart J 2006; 27: 2840-5.
172. Mullner M, Sterz F, Domanovits H, et al. The association between blood
lactate concentration on admission, duration of cardiac arrest, and functional
neurological recovery in patients resuscitated from ventricular fibrillation.
Intensive Care Med 1997; 23: 1138-43.
173. Booth CM, Boone RH, Tomlinson G, Detsky AS. Is this patient dead,
vegetative, or severely neurologically impaired? Assessing outcome for
comatose survivors of cardiac arrest. JAMA 2004; 291: 870-9.
174. Edgren E, Hedstrand U, Kelsey S, Sutton-Tyrrell K, Safar P. Assessment of
neurological prognosis in comatose survivors of cardiac arrest. BRCT I Study
Group. Lancet 1994; 343: 1055-9.
175. Madl C, Grimm G, Kramer L, et al. Early prediction of individual outcome after
cardiopulmonary resuscitation. Lancet 1993; 341: 855-8.
176. Chen R, Bolton CF, Young B. Prediction of outcome in patients with anoxic
coma: a clinical and electrophysiologic study. Crit Care Med 1996; 24: 672-8.
177. Johkura K, Komiyama A, Kuroiwa Y. Vertical conjugate eye deviation in
postresuscitation coma. Ann Neurol 2004; 56: 878-81.
178. Bassetti C, Bomio F, Mathis J, Hess CW. Early prognosis in coma after
cardiac arrest: a prospective clinical, electrophysiological, and biochemical
study of 60 patients. J Neurol Neurosurg Psychiatry 1996; 61: 610-5.
179. Wijdicks EF, Parisi JE, Sharbrough FW. Prognostic value of myoclonus status
in comatose survivors of cardiac arrest. Ann Neurol 1994; 35: 239-43.
180. Cheliout-Heraut F, Durand MC, Clair B, Gajdos P, Raphael JC. [Importance
of evoked potentials in the evolutive prognosis of coma during cerebral anoxia
in adults]. Neurophysiol Clin 1992; 22: 269-80.
181. Pfeifer R, Borner A, Krack A, et al. Outcome after cardiac arrest: predictive
values and limitations of the neuroproteins neuron-specific enolase and
protein S-100 and the Glasgow Coma Scale. Resuscitation 2005; 65: 49-55.
182. Zandbergen EG, de Haan RJ, Stoutenbeek CP, Koelman JH, Hijdra A.
Systematic review of early prediction of poor outcome in anoxic-ischaemic
coma. Lancet 1998; 352: 1808-12.
183. Arnoldus EP, Lammers GJ. Postanoxic coma: good recovery despite
myoclonus status. Ann Neurol 1995; 38: 697-8.
184. Harper SJ, Wilkes RG. Posthypoxic myoclonus (the Lance-Adams syndrome)
in the intensive care unit. Anaesthesia 1991; 46: 199-201.
185. Morris HR, Howard RS, Brown P. Early myoclonic status and outcome after
cardiorespiratory arrest. J Neurol Neurosurg Psychiatry 1998; 64: 267-8.
186. Edgren E, Hedstrand U, Nordin M, Rydin E, Ronquist G. Prediction of
outcome after cardiac arrest. Crit Care Med 1987; 15: 820-5.
187. Hockaday JM, Potts F, Epstein E, Bonazzi A, Schwab RS.
Electroencephalographic Changes in Acute Cerebral Anoxia from Cardiac or
Respiratory Arrest. Electroencephalogr Clin Neurophysiol 1965; 18: 575-86.
188. Lemmi H, Hubbert CH, Faris AA. The electroencephalogram after
resuscitation of cardiocirculatory arrest. J Neurol Neurosurg Psychiatry 1973;
36: 997-1002.
189. Young GB, Doig G, Ragazzoni A. Anoxic-ischemic encephalopathy: clinical
and electrophysiological associations with outcome. Neurocrit Care 2005; 2:
159-64.
190. Berek K, Lechleitner P, Luef G, et al. Early determination of neurological
outcome after prehospital cardiopulmonary resuscitation. Stroke 1995; 26:
543-9.
191. Madl C, Kramer L, Domanovits H, et al. Improved outcome prediction in
unconscious cardiac arrest survivors with sensory evoked potentials
compared with clinical assessment. Crit Care Med 2000; 28: 721-6.
192. Gendo A, Kramer L, Hafner M, et al. Time-dependency of sensory evoked
potentials in comatose cardiac arrest survivors. Intensive Care Med 2001; 27:
1305-11.
193. Logi F, Fischer C, Murri L, Mauguiere F. The prognostic value of evoked
responses from primary somatosensory and auditory cortex in comatose
patients. Clin Neurophysiol 2003; 114: 1615-27.
194. Tiainen M, Kovala TT, Takkunen OS, Roine RO. Somatosensory and
brainstem auditory evoked potentials in cardiac arrest patients treated with
hypothermia. Crit Care Med 2005; 33: 1736-40.
195. Tiainen M, Roine RO, Pettila V, Takkunen O. Serum neuron-specific enolase
and S-100B protein in cardiac arrest patients treated with hypothermia. Stroke
2003; 34: 2881-6.
196. Fogel W, Krieger D, Veith M, et al. Serum neuron-specific enolase as early
predictor of outcome after cardiac arrest. Crit Care Med 1997; 25: 1133-8.
197. Martens P, Raabe A, Johnsson P. Serum S-100 and neuron-specific enolase
for prediction of regaining consciousness after global cerebral ischemia.
Stroke 1998; 29: 2363-6.
198. Dauberschmidt R, Zinsmeyer J, Mrochen H, Meyer M. Changes of neuronspecific
enolase concentration in plasma after cardiac arrest and
resuscitation. Mol Chem Neuropathol 1991; 14: 237-45.
199. Rosen H, Rosengren L, Herlitz J, Blomstrand C. Increased serum levels of
the S-100 protein are associated with hypoxic brain damage after cardiac
arrest. Stroke 1998; 29: 473-7.
200. Bottiger BW, Mobes S, Glatzer R, et al. Astroglial protein S-100 is an early
and sensitive marker of hypoxic brain damage and outcome after cardiac
arrest in humans. Circulation 2001; 103: 2694-8.
201. Longstreth WT, Jr., Clayson KJ, Sumi SM. Cerebrospinal fluid and serum
creatine kinase BB activity after out-of-hospital cardiac arrest. Neurology
1981; 31: 455-8.
202. Clemmensen P, Strandgaard S, Rasmussen S, Grande P. Cerebrospinal fluid
creatine kinase isoenzyme BB levels do not predict the clinical outcome in
patients unconscious following cardiac resuscitation. Clin Cardiol 1987; 10:
235-6.
203. Roine RO, Somer H, Kaste M, Viinikka L, Karonen SL. Neurological outcome
after out-of-hospital cardiac arrest. Prediction by cerebrospinal fluid enzyme
analysis. Arch Neurol 1989; 46: 753-6.
204. Tirschwell DL, Longstreth WT, Jr., Rauch-Matthews ME, et al. Cerebrospinal
fluid creatine kinase BB isoenzyme activity and neurologic prognosis after
cardiac arrest. Neurology 1997; 48: 352-7.
205. Rothstein TL, Thomas EM, Sumi SM. Predicting outcome in hypoxic-ischemic
coma. A prospective clinical and electrophysiologic study. Electroencephalogr
Clin Neurophysiol 1991; 79: 101-7.
Дата добавления: 2015-09-27 | Просмотры: 569 | Нарушение авторских прав
|